Literature DB >> 3021884

Very low and low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid.

J L Ellsworth, S K Erickson, A D Cooper.   

Abstract

The liver is a major source of the plasma lipoproteins; however, direct studies of the regulation of lipoprotein synthesis and secretion by human liver are lacking. Dense monolayers of Hep-G2 cells incorporated radiolabeled precursors into protein ([35S]methionine), cholesterol ([3H]mevalonate and [14C]acetate), triacylglycerol, and phospholipid ([3H]glycerol), and secreted them as lipoproteins. In the absence of free fatty acid in the media, the principal lipoprotein secretory product that accumulated had a density maximum of 1.039 g/ml, similar to serum low density lipoprotein (LDL). ApoB-100 represented greater than 95% of the radiolabeled apoprotein of these particles, with only traces of apoproteins A and E present. Inclusion of 0.8 mM oleic acid in the media resulted in a 54% reduction in radiolabeled triacylglycerol in the LDL fraction and a 324% increase in triacylglycerol in the very low density lipoprotein (VLDL) fraction. Similar changes occurred in the secretion of newly synthesized apoB-100. The VLDL contained apoB-100 as well as apoE. In the absence of exogenous free fatty acid, the radiolabeled cholesterol was recovered in both the LDL and the high density lipoprotein (HDL) regions. Oleic acid caused a 50% decrease in HDL radiolabeled cholesterol and increases of radiolabeled cholesterol in VLDL and LDL. In general, less than 15% of the radiolabeled cholesterol was esterified, despite the presence of cholesteryl ester in the cell. Incubation with oleic acid did not cause an increase in the total amount of radiolabeled lipid or protein secreted. We conclude that human liver-derived cells can secrete distinct VLDL and LDL-like particles, and the relative amounts of these lipoproteins are determined, at least in part, by the availability of free fatty acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021884

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  23 in total

1.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells.

Authors:  C D Byrne; N P Brindle; T W Wang; C N Hales
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  Further cellular investigation of the human hepatoblastoma-derived cell line HepG2: morphology and immunocytochemical studies of hepatic-secreted proteins.

Authors:  M E Bouma; E Rogier; N Verthier; C Labarre; G Feldmann
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

4.  Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells.

Authors:  T L Carlson; B A Kottke
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

5.  Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH7777 rat hepatoma cultures.

Authors:  J C Fox; R V Hay
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

6.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

7.  Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.

Authors:  C D Byrne; T W Wang; C N Hales
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

8.  Research of an in vitro model to study the expression of fatty acid-binding proteins in the small intestine.

Authors:  A Mallordy; P Besnard; H Carlier
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

9.  Butyrate stimulates the secretion of apolipoprotein (apo) A-I and apo B100 by the human hepatoma cell line Hep G2. Induction of apo A-I mRNA with no change of apo B100 mRNA.

Authors:  A Kaptein; L Roodenburg; H M Princen
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

10.  Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux.

Authors:  Jane V Mulcahy; Dave R Riddell; James S Owen
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.